Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Human papillomavirus (HPV) infection, usually a sexually transmitted disease, is a risk factor for cervical cancer. Given the substantial disease and death associated with HPV and cervical cancer, development of a prophylactic HPV vaccine is a public health priority. We evaluated the cost-effectiven...
| Published in: | Emerging Infectious Diseases |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Centers for Disease Control and Prevention
2003-01-01
|
| Subjects: | |
| Online Access: | https://wwwnc.cdc.gov/eid/article/9/1/02-0168_article |